Burkina Faso vs United Arab Emirates: HIV-positive TB patients on ART (antiretroviral therapy)
Burkina Faso
100.0%
in 2024
United Arab Emirates
100.0%
in 2024
Burkina Faso rank
1st
United Arab Emirates rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burkina Faso
- United Arab Emirates
How they compare
Burkina Faso currently reports 100.0% against 100.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2010 it was United Arab Emirates ahead.
Burkina Faso ranks 1st and United Arab Emirates ranks 1st of 144 countries.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.0% | 87.5% | 7.5% | United Arab Emirates |
| 2020s | 94.2% | 100.0% | 5.8% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burkina Faso or United Arab Emirates?
- Burkina Faso, at 100.0% against 100.0% in United Arab Emirates as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burkina Faso and United Arab Emirates?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and United Arab Emirates?
- 13 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and United Arab Emirates rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burkina Faso ranks 1st and United Arab Emirates ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.